ArticleCancer gene therapy2006

Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.

D-E Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.